Stephens Inc Geron Corp Transaction History
Stephens Inc
- $6.77 Billion
- Q3 2024
A detailed history of Stephens Inc transactions in Geron Corp stock. As of the latest transaction made, Stephens Inc holds 45,443 shares of GERN stock, worth $158,596. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,443
Previous 70,824
35.84%
Holding current value
$158,596
Previous $300,000
31.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GERN
# of Institutions
274Shares Held
491MCall Options Held
1.87MPut Options Held
690K-
Black Rock Inc. New York, NY46.6MShares$162 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$154 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.4MShares$113 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$113 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$101 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.32B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...